Navigation Links
Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
Date:6/5/2009

SEATTLE, June 5 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) today announced that management will present at the following two investor conferences next week.

    Goldman Sachs 30th Annual Global Healthcare Conference
    Tuesday, June 9, 2009
    4:20 p.m. ET

    8th Annual Needham Life Sciences Conference
    Thursday, June 11, 2009
    11:00 a.m. ET

The presentations will be audio webcast live and available for replay from Dendreon's website, www.dendreon.com.

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets TRPM8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. The Company has its headquarters in Seattle, Washington and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit www.dendreon.com.


'/>"/>
SOURCE Dendreon Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Dendreon Corporation CEO Mitchell H. Gold, M.D. Named Ernst & Young Entrepreneur of the Year(R) 2009 Award Finalist in the Pacific Northwest
2. Dendreon Announces Closing of Common Stock Offering
3. Dendreon Announces Common Stock Offering
4. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
5. Dendreon Reports First Quarter 2009 Financial Results
6. Dendreon Announces Data Presentations and Webcast at AUA Annual Meeting
7. Dendreon Announces Data on PROVENGE Potency and Long-Term Immune Responses in Androgen-Dependent Prostate Cancer
8. Dendreon Reports Fourth Quarter and 2008 Year End Financial Results
9. Dendreon Announces Webcast Presentation at Eleventh Annual BIO CEO & Investor Conference
10. Dendreon Announces Webcast Presentation at 27th Annual J.P. Morgan Healthcare Conference
11. Dendreon Reports Third Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... , Aug. 22, 2014 Research and ... "Global Molecular Biology Enzymes, Kits, & Reagents (Cloning, Epigenetics, ... report to their offering. The ... million in 2013, and is expected to grow at ... 2018. Molecular biology enzymes, kits, & reagents find applications ...
(Date:8/21/2014)... Aug. 21, 2014  BioSpecifics Technologies Corp. (NASDAQ: ... first in class collagenase-based products marketed as XIAFLEX ... the U.S. and XIAPEX ® in the ... a randomized, double-blind Phase 2a study of CCH ... fibrosclerotic panniculopathy. The results showed that all three ...
(Date:8/21/2014)... DUBLIN, Ireland , August 21, 2014 ... and Markets ( http://www.researchandmarkets.com/research/3zh3q8/global_hormone ) has announced the ... Market 2014-2018"  report to their offering.  ... also known as hormone therapy, is a ... longer being produced by the body. This ...
(Date:8/21/2014)... Mathematic studies at the Program for Evolutionary Dynamics ... Jeffrey Epstein VI Foundation , have shown that the ... elimination. These aggressive cells are the driver mutations that drive ... of what to look for when examining tumors, comes at ... can be extracted from biopsy, it,s very difficult to know ...
Breaking Biology Technology:Global Molecular Biology Enzymes, Kits, & Reagents (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing) Market - Forecast to 2018 2Global Molecular Biology Enzymes, Kits, & Reagents (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing) Market - Forecast to 2018 3BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 2BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 3BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 4BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 5Global Hormone Replacement Therapy Market 2014-2018: Key Vendors are Actavis, Bayer, Merck & Co, Novartis and Novo Nordisk 2Science Power Jeffrey Epstein and Harvard University Fund Project to Visually Stop Tumor Growth 2
... 20 /PRNewswire-FirstCall/ - Oncothyreon Inc.,(Nasdaq: ONTY ... U.S. Patent and,Trademark office has issued a ... in preclinical development. The newly issued patent, ... composition of matter of PX-867,and pharmaceutical preparations ...
... 19 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc.,(Nasdaq: SSRX ... fully integrated,biotechnology company focused on researching, developing, ... announced today,that its board of directors has ... board has authorized 3SBio to purchase up ...
... CAMBRIDGE, Mass., March 19 Genzyme Corp.,(Nasdaq: ... application,to extend the Evoltra(R) (clofarabine) product label to include ... This,application and the data on which it was based ... by Genzyme last year., In a letter to ...
Cached Biology Technology:Oncothyreon announces issuance of patent for PX-867 2Oncothyreon announces issuance of patent for PX-867 33SBio Inc. Approves Share Repurchase Program 2Genzyme Withdraws Bioenvision's European Filing of Evoltra(R) in Elderly AML Patients 2Genzyme Withdraws Bioenvision's European Filing of Evoltra(R) in Elderly AML Patients 3
(Date:8/21/2014)... but they are the ultimate source of all organic ... dependent on algae, too, to suck up climate-warming carbon ... bottom of the ocean. Now, by using a combination ... showing that viruses infecting those algae are driving the ... else stays essentially the same, and this has important ...
(Date:8/21/2014)... 2014 /PRNewswire-iReach/ -- LiveScan Service Provider  Binary ... a partnership with Gabriel Health Institute, one of ... Certified Nursing Assistant preparatory schools. The agreement ... member of Binary,s LiveScan service provider,s owner/operator team; ... its service capabilities by widening the service ...
(Date:8/21/2014)... -- Nine researchers from Beth Israel Deaconess ... in "The World,s Most Influential Scientific Minds 2014," ... Thomson Reuters ScienceWatch, a web resource for science metrics ... recognized as among the most influential "are performing and ... the advancement of their science," according to a Thomson ...
Breaking Biology News(10 mins):Viruses take down massive algal blooms, with big implications for climate 2LiveScan Provider Binary Biometrics Announces Partnership with Preeminent CNA School, Gabriel Health Institute to Expand Services in Orlando Region 2LiveScan Provider Binary Biometrics Announces Partnership with Preeminent CNA School, Gabriel Health Institute to Expand Services in Orlando Region 3BIDMC researchers named among 'the most influential scientific minds' 2BIDMC researchers named among 'the most influential scientific minds' 3
... For Immediate Release - The Scripps Research Institute has ... J. John Goodman, M.D., to Scripps Florida. The gift will ... the development of a new approach to detect and treat ... program endowment. "We are grateful to Jay and Judy ...
... Researchers have uncovered the genetic basis of remarkable broad-spectrum ... the world, is the most important pathogen affecting leafy and ... oilseed rape. They have tested resistant plants against a range ... the world and so far, no strain has been able ...
... CINCINNATIA new international population study, led by the University ... human developmental effects of environmental exposure to the complex ... UC epidemiologist Aimin Chen, MD, PhD, says research on ... in e-waste is urgently needed in order to avoid ...
Cached Biology News:New disease-resistant food crops in prospect 2Human health effects of 'e-waste' focus of international research study 2
Mouse Amphiregulin MAb (Clone 206220)...
Anti-Digoxigenin-AP, Fab fragments; from sheep...
The antibody recognizes the peptide sequence ESESQGPK (aa 441-448) of human class III beta-tubulin specific for neurones....
Unique enzyme blend containing Taq and Pwo DNA Polymerase and another thermostable enzyme. The Expand 20 kbPLUS PCR System also includes an optimized reaction buffer, MgCl2 solution, and a human cont...
Biology Products: